Dräger JM-105 Notice D'utilisation page 126

Références
21 Juster-Reicher A, et al. Correlation of
transcutaneous bilirubinometry (TcB) and total
serum bilirubin (TSB) levels after
phototherapy. J Matern Fetal Neonatal Med.
2014:1-3.
22 Casnocha Lucanova L, et al. Accuracy of
transcutaneous bilirubin measurement in
newborns after phototherapy. J Perinatol.
2016;36(10):858-861.
23 Nagar G, et al. Reliability of transcutaneous
bilirubin devices in preterm infants: a
systematic review. Pediatrics.
2013;132(5):871-881.
24 Quist FK, et al. Clinical utility of
transcutaneous bilirubinometer (TcB) in very
low birth weight (VLBW) infants. J Perinat
Med. 2016;44(8):933-939.
25 Jnah A, Newberry DM, Eisenbeisz E.
Comparison of Transcutaneous and Serum
Bilirubin Measurements in Neonates 30 to 34
Weeks' Gestation Before, During, and After
Phototherapy. Adv Neonatal Care.
2018;18(2):144-153.
26 Raimondi F, et al. Measuring transcutaneous
bilirubin: a comparative analysis of three
devices on a multiracial population. BMC
Pediatr. 2012;12:70.
27 Taylor JA, et al. Discrepancies between
transcutaneous and serum bilirubin
measurements. Paediatrics.
2015;135(2):224-231.
28 Zou GY. Confidence interval estimation for the
Bland-Altman limits of agreement with multiple
observations per individual. Stat Methods Med
Res. 2013;22(6):630-642.
29 Sgro, M, Shah, V, Twiss, J. Investigating The
Agreement Between Transcutaneous Bilirubin
Measurements Using the JM-105 and Total
Serum Bilirubin Measurements By Site,
Before, During and After Phototherapy in an
ethnically diverse population of infants ≥ 24
weeks gestation. Clinical study. 2019.
120
Notice d'utilisation JM-105